Circulating Levels of C1q/TNF-Related Protein-12 (CTRP-12) in Patients with Type 2 Diabetes: A Case-control Study

Authors

  • Hadi Khodabandehloo Assistant Professor, Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  • Sattar Gorgani-Firuzjaee Assistant Professor, Department of Medical Laboratory Sciences, School of Allied Health Medicine, AJA University of Medical sciences, Tehran, Iran
Abstract:

Background: The C1q complement/TNF-related protein (CTRP) superfamily is a newly diagnosed adipokine with anti-inflammatory, insulin sensitivity, and glucose lowering effects. This study aimed to assess the plasma circulating levels of CTRP12 in type 2 diabetic (T2D) patients and healthy subjects. Methods: In this case-control study, plasma concentration of CTRP12 was measured by ELISA in 60 subjects (30 T2D and 30 healthy participants). The systolic blood pressure (SBP), waist circumference (WC), waist-to-hip ratio (WHR), body mass index (BMI), fasting blood sugar (FBS), glycated hemoglobin (HbA1c), insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) were measured. Results:In contrast to the SBP, WC, WHR, BMI, FBS, HbA1c, insulin, and HOMA-IR, the levels of CTRP12 were significantly lower in T2D patients. There was significant negative correlation between CTRP12, FBS, and HbA1c. The regression analysis showed that when subjected to stepwise multiple regression analysis, HbA1c (β = -2.21; P < 0.004) was predictive of plasma levels of CTRP12. Conclusion: Finally, HbA1c was predictive of CTRP12 levels. It seems that CTRP12 could be considered as a novel biomarker for the prediction of T2D.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

THE EFFECTS OF AEROBIC, RESISTANCE, AND COMBINED EXERCISE ON C1Q/TNF-RELATED PROTEIN-5 (CTRP-5) LEVELS AND GLYCEMIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Background: It has been shown that C1q TNF-related protein 5 (CTRP5) is a novel adipokine and important molecule related to metabolism regulation. This study aims to assess the effectiveness of different training protocols on improving serum levels of CTRP5, fasting blood glucose, insulin, Insulin resistance in patients with T2DM. Methods: Sixty men with T2DM (mean age [X̅±SD]=51.45±4.26 years)...

full text

Oxidized LDL is Correlated with Urine Albumin in Type 2 Diabetes Mellitus: A Case-Control Study

Objective: In patients with diabetes mellitus, increased rate of lipoprotein oxidation and oxidative stress have important role in diabetic angiopathy, including nephropathy. We designed a study for comparing the level of Ox-LDL in diabetic patients with Macro-albuminuria, Micro-albuminuria, versus Normo-albuminuric. Materials and Methods: One hundred and thirty five patients with type 2 dia...

full text

hearing loss and associated factors in iranian patients with type 2 diabetes: a case-control study

conclusions according to the results, hearing impairment in high frequency sounds was more common in the diabetics than the healthy individuals. also, the severity of hearing loss in patients with diabetes was associated with the levels of creatinine (diabetic nephropathy). the hypothesis of the relationship between diabetes and hearing loss through nephropathy should be more examined in future...

full text

The Relationship between Serum Levels of Irisin with Cardiometabolic Biomarkers in Patients with Type 2 Diabetes

Background: Diabetes and obesity are associated with an increased risk of cardiovascular disease. Irisin is a newly recognized peptidic myokine with anti-obesity and anti-diabetic properties. This study aims to investigate the relationship between serum irisin levels with cardiometabolic biomarkers in patients with type 2 diabetes mellitus (T2DM). Methods: In this comparative cross- sectional s...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 27  issue 3

pages  262- 269

publication date 2020-05-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023